Data submission simplified for the same preparation with different strengths.

Published: 2005-08-09 06:58:00

Updated: 2005-08-09 06:58:00

The data to submit for the KFDA registration will be far simplified if the drug be the same dosage form but different strengths, and the domestic clinical study may be restrictively permissible for the use of reference drugs that are not registered in Korea but only available in the overseas mark...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK